Stem Cells Research - Research, Transplants, Therapy, Benefits

Stem Cells Research Today is a free monthly online journal that collates and summarizes the latest research about Stem Cells, including details on research, transplants, therapy, benefits.


Stem Cells Research Today

Home

View Latest Issue

Information About Stem Cells

Books on Stem Cells

Advertising in Research Today

View Other Research Today Publications



Functional Outcome of Bone Marrow Stem Cells (CD45(+)/CD34(-)) After Cell Therapy in Chronic Spinal Cord Injury in Wistar Rats.

Carvalho KA, Vialle EN, Moreira GH, Cunha RC, Simeoni RB, Francisco JC, Guarita-Souza LC, Oliveira L, Zocche L, Olandoski M

Instituto de Ciências Biológicas e da Saúde, da Pontificia Universidade Católica do Paraná (ICBS-PUCPR), Curitiba, Brazil; Divisao de Bioprocessos do Departamento de Engenharia da UFPR, Curitiba, Brazil; Instituto de Pesquisa Pelé Pequeno Príncipe–Complexo Hospitalar Pequeno Príncipe, Curitiba, Brazil.

BACKGROUND: Therapy with diverse cell types has been proposed to regenerate spinal cord injuries seeking to minimize the consequences for the lives of chronic patients. The types considered are: mononuclear and mesenchymal adult stem cells, embryonic stem cells, and Schwann cells. MATERIALS AND METHODS: Ninety male Wistar rats that underwent spinal cord contusion injury (NYU Impactor) were followed with the Basso, Beattie, and Bresnahan (BBB) locomotor rating scale for 14 days. Animals with scores </=16 were randomly divided into 2 groups: control (vehicle) versus cell therapy group. The mononuclear fraction (CD45(+)/CD34(-)) obtained by puncture-aspiration of the bone marrow was isolated by a density gradient (d = 1.077). The parenchymal cell infusion was performed using a syringe (100 U/1 mL) with a 30G1/2 needle. The animals were followed for 10 days before euthanasia. Statistical analyses comparing groups were performed by the Mann-Whitney test and group comparisons by the Wilcoxon test. RESULTS: Among 90 injured rats, 65 (72.2%) survived, including 44 whose scores were </=16. Eleven animals finished the study in the control group (64.7%) and 17 in the therapy group (80.9%). The statistical analyses did not demonstrate significance (P > .05) for either test. CONCLUSION: Mononuclear adult stem cell therapy was not demonstrated to be functionally effective for chronic spinal cord injury.

Published 5 May 2008 in Transplant Proc, 40(3): 845-846.
Full-text of this article is available online (may require subscription).

Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Stem Cells Research Today. All Rights Reserved.



Stem Cells Research Today Archive:

Volume 1 (2004)
  Issue 1 (July)
  Issue 2 (August)
  Issue 3 (September)
  Issue 4 (October)
  Issue 5 (November)
  Issue 6 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)



Stem Cells Books

God and the Embryo

God and the Embryo